Patent 8148962

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-pro

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

1 settled
Terminated
Filed
Oct 16, 2025
Last modified
Mar 12, 2026
Petitioner
Micron Technology, Inc. et al.
Inventor
Tomer Shaul Elran

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Based on the provided information and public records, here is an analysis of the AIA trial proceedings for US patent 8,148,962.

Proceedings overview

One Inter Partes Review (IPR) has been filed against US patent 8,148,962. This proceeding was terminated by the parties before the Patent Trial and Appeal Board (PTAB) made a decision on whether to institute a trial. As a result, no claims have been invalidated or sustained by the PTAB. For a defendant, this means the patent's validity remains entirely untested in a post-grant proceeding, presenting both an opportunity to challenge the patent on a clean slate and the risk of facing a patent that has not been weakened or narrowed.

IPR2025-01561 — Micron Technology, Inc. et al. v. Palisade Technologies LLP

  • Type: Inter Partes Review
  • Filed: 2025-10-16
  • Status: Terminated — The proceeding was concluded on 2026-03-12 at the parties' request, prior to any decision on the merits of the patentability challenge.
  • Judge panel: Public records for proceedings terminated this early may not always list the assigned panel, and I do not have access to that specific information at this time.
  • Petition grounds: I do not have access to the specific petition documents to detail the exact claims challenged or the prior art asserted under § 102 or § 103. However, an IPR petition would have challenged the patentability of one or more claims based on prior art consisting of patents or printed publications.
  • Institution decision: No decision on institution was made. The PTAB terminated the proceeding before the statutory deadline for such a decision.
  • Final Written Decision: None was issued.
  • Settlement / termination: The "Terminated" status, particularly when it occurs before an institution decision, strongly indicates that the petitioner (Micron) and the patent owner (Palisade) reached a settlement in the parallel district court litigation (W.D. Tex. case 7:24-cv-00262). The parties would have filed a joint motion to terminate the IPR, which the Board granted. The specific terms of such settlements are typically confidential.
  • Appeal: Not applicable. An appeal to the Federal Circuit can only be taken from a Final Written Decision.
  • Defensive value: This proceeding offers significant intelligence but no direct defensive benefit. Because it was terminated before a Final Written Decision was issued, no statutory estoppel applies under 35 U.S.C. § 315(e). A new defendant can reuse the exact same prior art and arguments from Micron's petition in a new IPR or in district court. The petition itself serves as a ready-made invalidity roadmap developed by a sophisticated party.

Strategic summary

The key takeaway for any company facing this patent is that its validity has never been adjudicated by the PTAB.

  • Claim Status: All claims of US patent 8,148,962 (claims 1-20) remain valid and enforceable. No claims are CANCELED or have been SUSTAINED by the PTAB, meaning they are all UNTESTED in post-grant proceedings.
  • Estoppel Landscape: There is currently no IPR estoppel against any party. Under 35 U.S.C. § 315(e)(2), estoppel only attaches after the PTAB issues a Final Written Decision. Since IPR2025-01561 was terminated pre-institution, the petitioner (Micron Technology, Inc.) and its privies are not barred from raising the same grounds again. A new defendant has complete freedom to challenge any claim of the patent at the PTAB on any available prior-art ground.
  • Pattern Signals: The patent's assignment history—from the original inventor to SanDisk, then to Western Digital, and ultimately to Palisade Technologies, LLP in mid-2024—is characteristic of a patent being transferred to a patent assertion entity for monetization. The fact that the patent owner settled with a large defendant like Micron before the institution decision may signal a strategy to avoid a merits-based validity review by the PTAB, which could jeopardize their assertion campaign against other targets.

Recommended next steps

For a defendant currently facing an assertion of US patent 8,148,962, the path is clear: the patent is vulnerable to a validity challenge, and the prior IPR attempt provides a valuable head start.

  • Obtain the IPR Petition: Your first step should be to acquire the full petition and exhibits filed by Micron in IPR2025-01561 from the USPTO's PTAB End-to-End Search system. This document package contains a fully-formed invalidity attack, including expert declarations and claim charts, which can be evaluated, adopted, or improved upon for your own defense.
  • Assess and File Your Own IPR: The arguments that were persuasive enough for Micron to file an IPR may be equally or more persuasive to the PTAB. Given the patent owner's apparent preference for settling rather than facing an institution decision, filing a strong IPR petition is a potent strategy that creates significant leverage for achieving a favorable, early resolution.
  • No Pending Proceedings: There are no active PTAB proceedings or upcoming milestones to monitor for this patent. The defensive initiative rests with the next company that is targeted.

Generated 5/13/2026, 12:14:34 AM